Urogynaecological (transvaginal) surgical mesh hub

Urogynaecological mesh implants have benefited some women in the treatment of pelvic organ prolapse and stress urinary incontinence. Other women, however, have experienced very serious complications with these devices.

The Therapeutic Goods Administration (TGA) cancelled the approval of two specific types of urogynaecological mesh in November 2017:

• urogynaecological mesh that was inserted through the vagina to treat pelvic organ prolapse
• single incision mini-slings that were used to treat stress urinary incontinence.

These types of mesh device cannot be supplied in Australia.

The TGA continues to monitor the safety of all urogynaecological mesh implants. Please report any adverse events associated with these devices.

As of 23 June 2021, the TGA had received 899 adverse event reports related to urogynaecological mesh devices.